Evidence map›Paper›PMID 16292982›Full record

ArticlePLoS biology2005

Securin is not required for chromosomal stability in human cells.

Katrin Pfleghaar, Simone Heubes, Jürgen Cox, Olaf Stemmann, Michael R Speicher

Abstract read
In one paragraph

Article in PLoS biology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Accumulation of Securin on Spindle During Female Meiosis I.Frontiers in cell and developmental biology · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The Role of Aneuploidy in Cancer Evolution.Cold Spring Harbor perspectives in medicine · 2017
    Review
  14. Article
  15. The sister bonding of duplicated chromosomes.Seminars in cell & developmental biology · 2011
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Katrin PfleghaarInstitute of Human Genetics, Technical University Munich, Munich, Germany.
Simone Heubes
Jürgen Cox
Olaf Stemmann
Michael R Speicher

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Abnormalities of chromosome number are frequently observed in cancers. The mechanisms regulating chromosome segregation in human cells are therefore of great interest. Recently it has been reported that human cells without an hSecurin gene lose chromosomes at a high frequency. Here we show that, after hSecurin knockout through homologous recombination, chromosome losses are only a short, transient effect. After a few passages hSecurin(-/-) cells became chromosomally stable and executed mitoses normally. This was unexpected, as the securin loss resulted in a persisting reduction of the sister-separating protease separase and inefficient cleavage of the cohesin subunit Scc1. Our data demonstrate that securin is dispensable for chromosomal stability in human cells. We propose that human cells possess efficient mechanisms to compensate for the loss of genes involved in chromosome segregation.

Indexed as

AnaphaseCell Cycle ProteinsCell LineChromosomal InstabilityChromosomal Proteins, Non-HistoneEndopeptidasesHumansIn Situ Hybridization, FluorescenceNeoplasm ProteinsNuclear ProteinsPhosphoproteinsSaccharomyces cerevisiae ProteinsSecurinSeparaseCell Cycle ProteinsChromosomal Proteins, Non-HistoneEndopeptidasesESP1 protein, S cerevisiaeESPL1 protein, humanMCD1 protein, S cerevisiaeNeoplasm ProteinsNuclear ProteinsPhosphoproteinspituitary tumor-transforming protein 1, humanSaccharomyces cerevisiae ProteinsSecurinSeparase

Identifiers

PMID16292982
PMCPMC1287505

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.